Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Metabolism of docetaxel in mice.

Bardelmeijer HA, Roelofs AB, Hillebrand MJ, Beijnen JH, Schellens JH, van Tellingen O.

Cancer Chemother Pharmacol. 2005 Sep;56(3):299-306. Epub 2005 Apr 30.

PMID:
15864592
2.

Cannulation of the jugular vein in mice.

van Tellingen O, Bardelmeijer HA, Buckle T, Ouwehand M, Beijnen JH, Schellens JH.

Lab Anim. 2005 Jan;39(1):130. No abstract available.

PMID:
15703135
3.

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.

Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O.

Invest New Drugs. 2004 Aug;22(3):219-29.

PMID:
15122069
4.

Cannulation of the jugular vein in mice: a method for serial withdrawal of blood samples.

Bardelmeijer HA, Buckle T, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O.

Lab Anim. 2003 Jul;37(3):181-7.

PMID:
12869279
5.

Metabolism of paclitaxel in mice.

Bardelmeijer HA, Oomen IA, Hillebrand MJ, Beijnen JH, Schellens JH, van Tellingen O.

Anticancer Drugs. 2003 Mar;14(3):203-9.

PMID:
12634614
6.

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JH, Beijnen JH, van Tellingen O.

Cancer Res. 2002 Nov 1;62(21):6158-64.

7.

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.

Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O.

Cancer Chemother Pharmacol. 2002 Feb;49(2):119-25. Epub 2001 Nov 20.

PMID:
11862425
8.

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.

Malingré MM, Schellens JH, Van Tellingen O, Ouwehand M, Bardelmeijer HA, Rosing H, Koopman FJ, Schot ME, Ten Bokkel Huinink WW, Beijnen JH.

Br J Cancer. 2001 Nov 16;85(10):1472-7.

9.

Determination of cyclosporin A in human and mouse plasma by reversed-phase high-performance liquid chromatography.

Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O.

J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):201-6.

PMID:
11710579
10.

Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

Bardelmeijer HA, Beijnen JH, Brouwer KR, Rosing H, Nooijen WJ, Schellens JH, van Tellingen O.

Clin Cancer Res. 2000 Nov;6(11):4416-21.

11.

Modulation of oral bioavailability of anticancer drugs: from mouse to man.

Schellens JH, Malingré MM, Kruijtzer CM, Bardelmeijer HA, van Tellingen O, Schinkel AH, Beijnen JH.

Eur J Pharm Sci. 2000 Dec;12(2):103-10. Review.

PMID:
11102737
12.

The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Bardelmeijer HA, van Tellingen O, Schellens JH, Beijnen JH.

Invest New Drugs. 2000 Aug;18(3):231-41. Review.

PMID:
10958591
13.

Derivatization in capillary electrophoresis.

Bardelmeijer HA, Lingeman H, de Ruiter C, Underberg WJ.

J Chromatogr A. 1998 May 20;807(1):3-26. Review.

PMID:
9646486
14.

Pre-, on- and post-column derivatization in capillary electrophoresis.

Bardelmeijer HA, Waterval JC, Lingeman H, van't Hof R, Bult A, Underberg WJ.

Electrophoresis. 1997 Nov;18(12-13):2214-27. Review.

PMID:
9456036

Supplemental Content

Loading ...
Support Center